Plain-English translation of NCT05296408 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combination treatment for people who had a stroke and lost significant arm function. The study uses MyoPro—a custom-fitted robotic device that fits on your arm and helps translate even small muscle signals into arm movements—paired with specialized motor learning therapy. Researchers want to see if using the device together with therapy helps you regain more arm movement than therapy alone.
Standard rehabilitation therapies don't work well enough for people with severe arm weakness after stroke, especially when the weakness has lasted a long time. The new treatment aims to help because the robotic device makes it easier for people with weak muscles to practice moving their arm, which is key to relearning movement.
You likely qualify if…
You likely don't qualify if…
You would attend in-person therapy sessions twice a week for 9 weeks (18 total sessions, each lasting 1.5 hours), during which you would wear the MyoPro device and work with a therapist on arm movements. After the clinic phase, you would practice at home for 9 more weeks, and then return for follow-up visits 6 weeks later. You would also undergo brain imaging (MRI) and brain stimulation testing (TMS) at the beginning and end of the study to measure changes in your brain and arm function.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States